Cargando…
Ability of Innate Defence Regulator Peptides IDR-1002, IDR-HH2 and IDR-1018 to Protect against Mycobacterium tuberculosis Infections in Animal Models
Tuberculosis is an ongoing threat to global health, especially with the emergence of multi drug-resistant (MDR) and extremely drug-resistant strains that are motivating the search for new treatment strategies. One potential strategy is immunotherapy using Innate Defence Regulator (IDR) peptides that...
Autores principales: | Rivas-Santiago, Bruno, Castañeda-Delgado, Julio E., Rivas Santiago, Cesar E., Waldbrook, Matt, González-Curiel, Irma, León–Contreras, Juan C., Enciso-Moreno, Jose Antonio, del Villar, Victor, Mendez-Ramos, Jazmin, Hancock, Robert E. W., Hernandez-Pando, Rogelio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605426/ https://www.ncbi.nlm.nih.gov/pubmed/23555622 http://dx.doi.org/10.1371/journal.pone.0059119 |
Ejemplares similares
-
Synthetic Cationic Peptide IDR-1018 Modulates Human Macrophage Differentiation
por: Pena, Olga M., et al.
Publicado: (2013) -
Impacts of PEGylation and Glycosylation on the Biological Properties of Host Defense Peptide IDR1018
por: Etayash, Hashem, et al.
Publicado: (2023) -
Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection
por: Wuerth, Kelli C., et al.
Publicado: (2017) -
IDR knowledge base for primary immunodeficiencies
por: Samarghitean, Crina, et al.
Publicado: (2007) -
Modulation of the immune response by the host defense peptide IDR-1002 in chicken hepatic cell culture
por: Sebők, Csilla, et al.
Publicado: (2023)